Identifying a typology of men who use anabolic androgenic steroids (AAS)

被引:69
作者
Zahnow, Renee [1 ]
McVeigh, Jim [2 ]
Bates, Geoff [2 ]
Hope, Vivian [2 ]
Kean, Joseph [2 ]
Campbell, John [3 ]
Smith, Josie [4 ]
机构
[1] Univ Queensland, Sch Social Sci, St Lucia, Qld 4072, Australia
[2] Liverpool John Moores Univ, Publ Hlth Inst, Henry Cotton Campus,15-21 Webster St, Liverpool L3 2ET, Merseyside, England
[3] Scottish Natl Blood Transfus Serv, Res Dev & Innovat, Edinburgh, Midlothian, Scotland
[4] Publ Hlth Wales, Hlth Promot, Cardiff, S Glam, Wales
关键词
Anabolic steroids; Image and performance enhancing drugs; Bodybuilding; Harm minimisation; Risk; CLUSTER-ANALYSIS; DRUG-USE;
D O I
10.1016/j.drugpo.2018.02.022
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Despite recognition that the Anabolic Androgenic Steroid (AAS) using population is diverse, empirical studies to develop theories to conceptualise this variance in use have been limited. Methods: In this study, using duster analysis and multinomial logistic regression, we identify typologies of people who use AAS and examine variations in motivations for AAS use across types in a sample of 611 men who use AAS. Results: The cluster analysis identified four groups in the data with different risk profiles. These groups largely reflect the ideal types of people who use AAS proposed by Christiansen et al. (2016): Cluster 1 (You Only Live Once (YOLO) type, n = 68, 11.1%) were younger and motivated by fat loss; Cluster 2 (Well-being type, n = 236, 38.6%) were concerned with getting fit; Cluster 3 (Athlete type, n = 155, 25.4%) were motivated by muscle and strength gains; Cluster 4 (Expert type, n = 152, 24.9%) were focused on specific goals (i.e. not 'getting fit'). Conclusion: The results of this study demonstrate the need to make information about AAS accessible to the general population and to inform health service providers about variations in motivations and associated risk behaviours. Attention should also be given to ensuring existing harm minimisation services are equipped to disseminate information about safe intra-muscular injecting and ensuring needle disposal sites are accessible to the different types.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [1] The use of anabolic androgenic steroids and polypharmacy: A review of the literature
    Dodge, Tonya
    Hoagland, Margaux F.
    DRUG AND ALCOHOL DEPENDENCE, 2011, 114 (2-3) : 100 - 109
  • [2] Anabolic androgenic steroids: A survey of 500 users
    Parkinson, AB
    Evans, NA
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (04) : 644 - 651
  • [3] Anabolic androgenic steroids: Use and perceived use in nonathlete college students
    Berning, Joseph M.
    Adams, Kent J.
    DeBeliso, Mark
    Stamford, Bryant A.
    Newman, Ian M.
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2008, 56 (05) : 499 - 503
  • [4] Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping
    Solimini, R.
    Rotolo, M. C.
    Mastrobattista, L.
    Mortali, C.
    Minutillo, A.
    Pichini, S.
    Pacifici, R.
    Palmi, I.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 : 7 - 16
  • [5] Aortopathic effect of androgenic anabolic steroids
    Mohammad Ali Babaee Bigi
    Firouzeh Abtahi
    Zahra Mehdipour Namdar
    Anis Amirhakimi
    Alireza Hosseinpour
    Shahab Shahrzad
    Amir Aslani
    Journal of Echocardiography, 2021, 19 : 113 - 117
  • [6] Aortopathic effect of androgenic anabolic steroids
    Bigi, Mohammad Ali Babaee
    Abtahi, Firouzeh
    Namdar, Zahra Mehdipour
    Amirhakimi, Anis
    Hosseinpour, Alireza
    Shahrzad, Shahab
    Aslani, Amir
    JOURNAL OF ECHOCARDIOGRAPHY, 2021, 19 (02) : 113 - 117
  • [7] Pharmacoepidemiology of anabolic androgenic steroids: a review
    Thiblin, I
    Petersson, A
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (01) : 27 - 44
  • [8] A model for evaluating the economic value of prevention programs for illicit use of anabolic androgenic steroids
    Sampaio, Filipa
    Ssegonja, Richard
    Thiblin, Ingemar
    Nystrand, Camilla
    HEALTH POLICY, 2021, 125 (06) : 807 - 813
  • [9] ADHD symptoms and use of anabolic androgenic steroids among male weightlifters
    Kildal, Emilie
    Hassel, Bjornar
    Bjornebekk, Astrid
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access
    Orlanda Harvey
    Steve Keen
    Margarete Parrish
    Edwin van Teijlingen
    BMC Public Health, 19